A bone-anchored hearing aid (BAHA) is a surgically implanted device designed to treat hearing loss by transmitting the sounds it receives through direct bone conduction to the nerve fibers of the inner ear. The device consists of an externally worn receiver and sound processor, which resembles a standard behind-the-ear hearing aid, and an external abutment that vibrates a titanium implant. The hearing aid is operational once the titanium fixture bonds with the surrounding tissue (osseointegration). This process usually takes two to six months from when the device has been implanted. Patients with conductive and mixed hearing loss are the primary candidates for bone-anchored hearing aids; this includes patients with chronic inflammation or infection of the ear canal which prevents the use of standard hearing aids, patients with conditions which have led to malformation of the ear canal, patients with single-sided deafness, patients with a bilateral conductive loss due to ossicular disease and patients who have malformed or absent outer ear and ear canals.
Growth in the prevalence of hearing loss amongst the pediatric and geriatric population is the major factor that drives the BAHA market. Furthermore, increase in demand for customized hearing devices and increase in technological advancements such as aesthetic hearing aids are anticipated to propel the market growth. However, presence of substitutes, such as hearing aids, cochlear implants, auditory brain stem implants, & vibrant soundbridge, and lack of standardization evaluation tools for BAHA, stringent government regulations related to the safety and efficacy of bone anchored hearing aids hinder the market growth. In addition, side effects associated with BAHA such as failure of osseointegration, chronic infection, skin irritation, and others are anticipated to hamper the BAHA market. Ongoing R&D activities related to BAHA are anticipated to present new opportunities for the market.
EMEA accounted for about 44% of the total share of the market and dominated the bone anchored hearing aids market during 2015. The presence of major vendors in this region, better reimbursement policies, and the availability of free hearing aids to affected individuals are major factors that will drive the growth of the market in this region.
The global Bone Anchored Hearing Aids market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bone Anchored Hearing Aids volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bone Anchored Hearing Aids market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bone Anchored Hearing Aids in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bone Anchored Hearing Aids manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Cochlear
MED-EL
William Demant
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sensorineural Hearing Loss
Conductive Hearing Loss
Mixed Hearing Loss
Single Sided Deafness
Segment by Application
Titanium Alloy
Ceramics Composites
Others
Summary:
Get latest Market Research Reports on Bone Anchored Hearing Aids. Industry analysis & Market Report on Bone Anchored Hearing Aids is a syndicated market report, published as Global Bone Anchored Hearing Aids Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Bone Anchored Hearing Aids market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.